Needham & Company Maintains a 'Strong Buy' on Teva Pharma (TEVA); To Be the Man, You Have to Beat the Man
Tweet Send to a Friend
Needham & Company maintains a 'Strong Buy' on Teva Pharma (NASDAQ: TEVA) price target of $58.00.
Needham analyst says, "Though ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Needham analyst says, "Though ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
